Paul J. Mellett
2013
In 2013, Paul J. Mellett earned a total compensation of $924.2K as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 101% increase compared to previous year.
Compensation breakdown
| Bonus | $114,603 |
|---|---|
| Option Awards | $499,527 |
| Salary | $305,624 |
| Other | $4,439 |
| Total | $924,193 |
Mellett received $499.5K in option awards, accounting for 54% of the total pay in 2013.
Mellett also received $114.6K in bonus, $305.6K in salary and $4.4K in other compensation.
Rankings
In 2013, Paul J. Mellett's compensation ranked 6,981st out of 12,286 executives tracked by ExecPay. In other words, Mellett earned more than 43.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,981 out of 12,286 | 43rd |
Division Manufacturing | 2,476 out of 4,612 | 46th |
Major group Chemicals And Allied Products | 752 out of 1,462 | 49th |
Industry group Drugs | 555 out of 1,156 | 52nd |
Industry Pharmaceutical Preparations | 443 out of 890 | 50th |
Source: SEC filing on January 13, 2016.
Mellett's colleagues
We found two more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2013.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019